GW Pharmaceuticals cannabis drug gets regulatory OK in Australia
GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in treating seizures related to […]
GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in treating seizures related to […]
Democrats in the U.S. House of Representatives decided this week to hold off on a floor vote for the Marijuana Opportunity Reinvestment […]
Marijuana extraction companies are among the industry leaders in innovation because the sector is continuously evolving. R&D, innovation are key for marijuana […]
Wildfires in the West have devastated a number of marijuana farms in Oregon, Washington state and California, while an early freeze hit […]
(This is an abridged version of the cover package that appears in the August issue of Marijuana Business Magazine.) The Illegal cannabis […]
(This is the second installment in a two-part series in which cannabis industry executives share their tips for getting through the coronavirus-induced […]
Though the U.S. government’s temporary lifeline to tens of millions of unemployed workers expired, sales of recreational marijuana products have proved resilient. […]
It’s been a little more than a week since the $600-per-week federal jobless benefits expired, and the toll that lack of extra […]
Several cannabis industry executives discuss steps that companies can take to survive the current recession. Cannabis industry veterans share measures they’ve taken […]
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding […]